First humans receive experimental drug ORKA-002 in safety trial
NCT ID NCT06944379
Summary
This is the very first study testing a new drug called ORKA-002 in humans. It aims to check if the drug is safe and to see how the body processes it after a single injection. The study involves about 24 healthy volunteers who will receive either the drug or a placebo. The main goal is to gather initial safety data before testing in people with a specific disease.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Oruka Therapeutics Investigative Site
Christchurch, New Zealand, New Zealand
Conditions
Explore the condition pages connected to this study.